Better liquidity and trading volumes may include CAU into the ASX 300 index for index funds
Also if this quarter the sales receipts are $25m+ that would equate to ~$4m to $5m in quarterly profits which annualised will be $100m in cash receipts which will allow CAU to significantly upgrade their FY23 forecast significantly and also pay another dividend by the end of the year.
CAU is slowly but surely cannabilising the whole MedCan sector in AU and scaling rapidly
